Ultraviolet Light Downregulates CD95 Ligand and Trail Receptor Expression Facilitating Actinic Keratosis and Squamous Cell Carcinoma Formation
- 1 July 2001
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 117 (1) , 59-66
- https://doi.org/10.1046/j.0022-202x.2001.01380.x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Loss of Fas-Ligand Expression in Mouse Keratinocytes during UV CarcinogenesisThe American Journal of Pathology, 2000
- The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis SystemsExperimental Cell Research, 2000
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L).Journal of Clinical Investigation, 1998
- Role of p53 in UVB-Induced Apoptosis in Human HaCaT KeratinocytesJournal of Investigative Dermatology, 1997
- An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILScience, 1997
- The Receptor for the Cytotoxic Ligand TRAILScience, 1997
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995
- Apoptosis in human skin development: Morphogenesis, periderm, and stem cellsDevelopmental Dynamics, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993